Aller au contenu principal
Profil bibliographique

Kevin H. Dang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

33Publications signalées
765Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy researchBiosimilars and Bioanalytical MethodsGlycosylation and Glycoproteins ResearchImmunotherapy and Immune Responses

Les publications récentes

2026 conference-abstract OpenAlex

Abstract TP060: Evaluation of the Satety Profile of the Tirofiban Protocol for Select Patients with Acute Ischemic Stroke at a United States Comprehensive Stroke Center

Kevin H. Dang, Josiah Chang, Diane C. McLaughlin, Tracie Schroeder et autres

Background and Purpose: Tirofiban, a glycoprotein IIb/IIIa receptor inhibitor, has been studied as an adjunctive treatment in patients with acute ischemic stroke. In the recent RESCUE BT2 trial in China, intravenous (IV) tirofiban in patients without medium or large vessel occlusions was …

us (code pays fourni par la source)

0 citations Stroke
Accès ouvert 2025 conference-abstract OpenAlex

820 Discovery of a novel CD123 x gamma delta T cell engager for the treatment of acute myeloid leukemia

Kevin H. Dang, Zahra Bahrami-Dizicheh, Harish Medlari, James Allison et autres

Background Gamma delta (γδ) T cells are a distinct subset of T cells with features of both innate and adaptive immunity. Based on their TCR δ chain usage, γδT cells can be divided into Vδ1 cells present in tissues, Vδ2 cells predominately …

us (code pays fourni par la source)

0 citations Regular and Young Investigator Award Abstracts
Accès ouvert 2025 article OpenAlex

Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD

Ghenima Ahmil-Boiteau, Pranjali Dalvi, Kevin H. Dang, Harshad S. Ugamraj et autres

Introduction: CD38 is highly expressed on immune cells. It catabolizes NAD+, which is a critical cofactor for enzymes involved in metabolism and energy production. Methods and results: We developed TNB-738, a fully human antibody that potently inhibits human CD38 enzymatic activity on …

fr, us (code pays fourni par la source)

1 citation Frontiers in Immunology
2025 article OpenAlex

Paraneoplastic Encephalitis Presenting as Subacute Hemidystonia, Ataxia, and Status Epilepticus in a Man with Neurodevelopmental Disorder and a Scrotal Germ Cell Tumor (P3-8.010)

Giovanni R. Malaty, Kevin H. Dang, Shafeeq S. Ladha, Michael Robers et autres

To present a case of KLHL11-Ma2/Ta Antibody Encephalitis in a man with adult-onset seizures, ataxia, subacute cognitive decline, and hemidystonia found to be antibody positive with a scrotal mixed germ-cell tumor.

us (code pays fourni par la source)

0 citations Neurology
2025 article OpenAlex

Severe Necrotizing Myositis in a Patient with Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR), Melanoma Differentiation-Associated Gene 5 (MDA-5), Clinically Amyopathic Dermatomyositis 140 (CADM-140), Nuclear Matrix Protein 2 (NXP-2), and Ribonucleoprotein (RNP) antibodies without Dermatologic Involvement (P3-11.017)

Kyle N. Kaneko, Kevin H. Dang, Erik Ortega

To present a case of severe immune mediated necrotizing myositis in a patient with autoantibodies to HGMCR, MDA-5, CADM-140, NXP-2, and RNP without dermatologic involvement that was minimally responsive to intravenous immune globulin (IVIG) requiring cyclophosphamide.

us (code pays fourni par la source)

0 citations Neurology
2025 article OpenAlex

Unmasking Lamotrigine Toxicity: Two Cases with Ocular Red Herrings and the Crucial Role of Vigilant Pharmacological Assessment (P9-11.001)

Alexa Rothenberg, Kevin H. Dang, Terry D. Fife

Lamotrigine (LTG) is a commonly used anticonvulsant and mood stabilizer. While generally well-tolerated, lamotrigine toxicity can occur. Presentation of lamotrigine toxicity can be diverse and include seizure, ocular abnormalities, ataxia, and encephalopathy, mimicking other neurological conditions, causing diagnostic challenges. Ocular findings are …

us (code pays fourni par la source)

1 citation Neurology
2024 conference-abstract OpenAlex

Abstract B037: AB-2100, a PSMA-inducible CA9-specific CAR T cell product intended for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Suchismita Mohanty, Jeremy Chen, Alma Gomez, Angela C. Boroughs et autres

Abstract Common challenges of CAR-T cell therapies in solid tumors, such as clear cell renal cell carcinoma (ccRCC), include insufficient therapeutic potency and tumor specificity. AB-2100 is an autologous integrated circuit T cell product generated via CRISPR-mediated knock-in of a single transgene …

us (code pays fourni par la source)

1 citation Cancer Immunology Research
2024 conference-abstract OpenAlex

Abstract 38: AB-2100, a PSMA-inducible CA9-specific CAR T cell product for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Suchismita Mohanty, Jeremy Chen, Alma Gomez, Angela C. Boroughs et autres

Abstract Common challenges of CAR-T cell therapies in solid tumors, such as clear cell renal cell carcinoma (ccRCC), include insufficient therapeutic potency and lack of tumor specificity. We have developed AB-2100, an autologous integrated circuit T (ICT) cell product, generated via CRISPR-mediated …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2023 conference-abstract OpenAlex

301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC

Irene Scarfò, Laura Lim, Kevin H. Dang, Marvin Chew et autres

Background Clinically effective CAR T cell therapy for solid tumors may require substantial T cell engineering to increase specificity and potency. We have developed AB-2100, an autologous, integrated circuit T (ICT) cell that encodes multiple synthetic ‘modules’ to overcome challenges in the …

us (code pays fourni par la source)

0 citations Regular and Young Investigator Award Abstracts
Accès ouvert 2022 article OpenAlex

TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity

Harshad S. Ugamraj, Kevin H. Dang, Laure‐Hélène Ouisse, Benjamin Buelow et autres

Cluster of differentiation 38 (CD38) is an ecto-enzyme expressed primarily on immune cells that metabolizes nicotinamide adenine dinucleotide (NAD+) to adenosine diphosphate ribose or cyclic ADP-ribose and nicotinamide. Other substrates of CD38 include nicotinamide adenine dinucleotide phosphate and nicotinamide mononucleotide, a critical …

fr, us, in (code pays fourni par la source)

27 citations mAbs
Accès ouvert 2021 article OpenAlex

Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release

Kevin H. Dang, Giulia Castello, Starlynn Clarke, Yuping Li et autres

Background Therapeutic options currently available for metastatic castration-resistant prostate cancer (mCRPC) do not extend median overall survival >6 months. Therefore, the development of novel and effective therapies for mCRPC represents an urgent medical need. T cell engagers (TCEs) have emerged as a …

us (code pays fourni par la source)

78 citations Journal for ImmunoTherapy of Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.